medigraphic.com
ISSN 1817-5996 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cub de Reu 2013; 15 (2)

Systemic sclerosis and pregnancy

López MAM, Hernández CMI, Prada HD, Molinero RC, Reyes PY

Language: Spanish
References: 27
Page:
PDF size: 113.48 Kb.


ABSTRACT

Systemic sclerosis is a not common disease, which is frequent in women with ages from 30 to 50 years old, generally after reproductive life, however, is not an exception that pregnancy will outcome because there is not any affection of fertility ability among this patients. It is well known that in those patients there is a higher incidence of pre-term birth and small full-term infants, without significant ratios of maternal complications. Clinical activity of SSc does not change during pregnancy according to most of the authors, although in patients which have pre-existence of nephropathy is common to develop toxemia and renal crisis could appear early. Respect to SSc treatment during pregnancy it must be personalized and should be used less drugs as possible. It is recommended that these patients must be treated by interdisciplinary equipment with rheumatologist included in order to reduce maternal-fetal and neonatal complications.


REFERENCES

  1. Valentini G, Medsger TA, Silman AJ, Bombardieri S. The assessment of the patient with systemic sclerosis. Clin Exp Rheumatol. 2003; Suppl 29(21): 2-30.

  2. Andreu JL, Sanz J, Mulero J. Esclerosis sistémica (esclerodermia) Reumatología Clínica. 2000; 8(30):1543-52.

  3. Bustabad S, Rodriguez B, Bethencourt JJ .Preesclerodermia .Semin Fund Esp Reumatol. 2011; 12(4):123-7.

  4. Silman AJ, Hochberg MC Occupational and environmental influences on scleroderma. Rheum Dis Clin N Am. 1996; 22: 737-49.

  5. Roa J. Avances en la Clasificación, Inmunopatogenia y Tratamiento de la Esclerodermia. Reumatología. 2005; 21(1):27-32.

  6. Black C, Denton C, Gay S, Huber L and Seybold J .Advances in systemic sclerosis and related fibrotic and vascular conditions. Arthritis Res Ther. 2007; Suppl 2(9): 47-S6.

  7. Vera-Lastra OL .Esclerosis sistémica y tracto gastrointestinal. Abordaje diagnóstico y terapéutico. Reumatología Clínica. 2006; 2(3).

  8. Strollo D; Goldin J .Imaging Lung Disease in Systemic Sclerosis.Curr Rheumatol Rep. 2010; 12:156-61.

  9. Jara LJ .Barrera A: Afección Renal en la Esclerosis Sistémica. Reumatología Clínica. 2006; 2(3):20-23.

  10. Mecacci F, Pieralli A, Paidas MJ. El impacto de los trastornos autoinmunes y los resultados adversos del embarazo. Semin Perinatol. 2007 Aug; 31(4):223-6.

  11. Fautrel B, Benhamou M. Enfermedades inflamatorias crónicas y la reproducción .Gynecol Obstet Fértil. 2007 Sep; 35 (9):848-52.

  12. Arlet CM, Smith JB, Jiménez SA. Identification of fetal DNA and cells in skin lesion from women with systemic sclerosis. N Eng J Med. 1998; 338:1186-91.

  13. Christmann de Souza et al: Avaliacao dos factores Reproductivos em 117 pacientes.com Esclerose Sistemica Forma Limitada e 72 pacientes com Artrite Reumatoide. Rev. Bras. Reumatol. 2005; 45(3):114-8.

  14. Rak JM, Pagni PP, Tiev K, Allanore Y, Farge D, Harlé JR et al .Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset. Rheumatology (Oxford). 2009 Apr;48(4):363-6.

  15. Burastero SE, Galbiati S, Vassallo A, Sabbadini MG, Bellone M, Marchionni L, et al.Cellular microchimerism as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosis. Arthritis Rheum. 2003 Apr;48(4):1109-16.

  16. Artlett CM, Rasheed M, Russo-Stieglitz KE, Sawaya HH, Jimenez SA .Influence of prior pregnancies on disease course and cause of death in systemic sclerosis. Ann Rheum Dis. 2002 Apr;61(4):346-50.

  17. Scaletti C, Vultaggio A, Bonifacio S,et al . Th2-oriented profile of male offspring T cell present in women with Systemic Sclerosis and reactive Major Histocompatibility Complets Antigens . Arthritis Rheum. 2002; 46:445-50.

  18. Steen VD, Brodeur M, Conte C. Prospective Pregnancy (PG) study in women with systemic sclerosis (SSc). Arthritis Rheum 1999; 39: 5151-63.

  19. Steen VD. Pregnancy in scleroderma. Rheum Dis Clin North Am. 2007 May;33(2):345-58.

  20. Toro CE, Quintana MA, Escobar MF, Cañas CA, Iglesias A, Restrepo JF. Enfermedad reumatológica y embarazo. Rev. Colombiana de Reumatologia.2007;14 (1): 54-64.

  21. Buitron R, Zaruma F, Rivas R, Romero R: Esclerosis sistémica (esclerodermia) y embarazo. Reporte de un caso. Revista Médica del Hospital General de México. 2004; 1 (6): 34-52.

  22. Chakravarty E, Khanna D, and Chung L. Pregnancy Outcomes in Systemic Sclerosis, Primary Pulmonary Hypertension, and Sickle Cell Disease. Obstetrics & Gynecology. 2008;111:927-34.

  23. Steen et al. Prospective Pregnancy (PG) study in women with systemic sclerosis. Obstet Gynecol. 1999; 3(7):31-9.

  24. Virginia DS, Thomas AM. Fertility and pregnancy outcome in women with systemic sclerosis. Am Col Rheumatol. 1999; 42 (4): 763-68.

  25. Chung L .Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. Lupus 2006; 15(9): 595-99.

  26. Ramírez E, Berrocal A , Calvo A. Esclerosis sistémica progresiva y embarazo: Reporte de 3 casos . Boletín de la Sociedad Peruana de Medicina Interna. 1999; 12 (2): 23-28.

  27. Miniati I, Guiducci S, Mecacci F, Mello G, Matucci-Cerinic M. Pregnancy in systemic sclerosis. Rheumatology (Oxford). 2008 Jun;Suppl 3(47):6-8.




2020     |     www.medigraphic.com